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• I know that I know nothing (eν οiδα oτι οuδeν οiδα). 
 Socrates. Greek Athenian philosopher 469 BC–399 BC. 
 
• Knowledge has to be improved, challenged, and increased constantly, or it vanishes.  
      Peter F. Drucker.  American writer and management consultant(1909-2005) 
 
• Distruction and contruction: the rhythm of life, of science, of human thinking and 
behavior. 
 
• Analysis and synthesis: the ongoing dialogue of science and knowledge. 
 
• To view the storm from behind, the damage has left, rejoicing it has gone by. 
 
• Sooner or later we break into thousand pieces. But we always think of us as endless.  
 
• An open mind view on the use of Magnetic Resonance and Nuclear Medicine Imaging 
may improve diagnostic accuracy of in IBD (Chapter 5). 
 
• Inflammation in Crohn’s disease may be detected by different MRI parameters with 
similar sensitivity but different intrinsic meaning (Chapter 2 and 4). 
 
• In Crohn’s disease, in order to use a biological treatment, such as the infliximab, the 
drug target (the cytokine Tumor Necrosis Factor-alpha) should be identified “in vivo” at 
the level of diseased intestinal segments (Chapter 6, 7). 
 
• In medicine the lack of interaction and integration between different subspecialties 
leads to take wrong paths. A multi-discipliner integrated approach is the key of modern 
medicine (Chapter 6). 
 
• In MRI T1 and T2-weighted tissue contrast can be optimized by using negative 
superparamagnetic intestinal contrast agents, allowing a complete assessment of 
bowel wall inflammatory changes in Crohn’s disease. (Chapter 4). 
 
• MRI can be safely used to investigate both morphologic features and inflammatory 
activity of Crohn’s disease in pediatric patients, that appear different from adults. A 
deeper understanding of the different inflammatory mechanisms in adult and pediatric 
patients is therefore needed (Chapter 8). 
 
• Frontiers of MRI in Crohn's disease are continuously moving forward. Imaging of water 
diffusion, of perfusion and in vivo MR spectroscopy are reducing the gap with 
molecular imaging (chapter 9) 
 
 
 
	  
